ViewRay Announces Proposed Public Offering of Common Stock

CLEVELAND, Nov. 16, 2021 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced that it has commenced an underwritten…

Click here to view the original article.